RELB and glioblastoma: To evaluate the relationship between FMNL1 expression and the mesenchymal GBM subtype, we quantified the expression levels of six genes we had previously profiled as representative mesenchymal markers (CHI3L1, CD44, VIM, RELB, TRADD, and PDPN) [24].